Zidovudine for early human immunodeficiency virus (HIV) infection: who, when, and how?
- PMID: 1970465
- DOI: 10.7326/0003-4819-112-10-721
Zidovudine for early human immunodeficiency virus (HIV) infection: who, when, and how?
Comment on
-
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.Ann Intern Med. 1990 May 15;112(10):727-37. doi: 10.7326/0003-4819-112-10-727. Ann Intern Med. 1990. PMID: 1970466 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical